Company intelligence / Profile preview

MDSURE

Ownership: Private
Development stage: Other

Overview

MDSURE provides cancer patients with individualized nutrition protocols based on advanced diagnostic schemes. Their proprietary method combines state-of-the-art diagnostics with scheduled food and supplement regimens designed to optimize chemotherapy outcomes, potentially prevent recurrence, and improve quality of life. The approach is supported by in vitro and in vivo results but does not represent traditional clinical trial stages for therapeutics.

Therapeutic areas: Oncology
Modalities: Non-pharmacological therapyDiagnostic service
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on MDSURE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MDSURE.

Explore the full profile